Patients with 1 HFpEF is increasingly prevalent among individuals with 1,2 The new study published in JAMA used 3 US claims data sources, all of which contained longitudinal patient-level information, including demographics, diagnoses, procedures, and outpatient prescription medications
Taking doses closer than the recommended 2-day minimum interval could theoretically increase drug exposure beyond intended levels, potentially intensifying these gastrointestinal symptoms
Here is what a competent provider evaluation includes before recommending either peptide: Baseline hormone panel including IGF-1, testosterone, thyroid, and cortisol Fasting blood glucose and metabolic markers (GH peptides can affect insulin sensitivity) Review of current medications and supplements for interactions Assessment of sleep quality, energy, recovery rate, and body composition trends Discussion of treatment goals and realistic expectations A protocol with defined monitoring checkpoints not a static dose-and-forget plan BPC-157, Ipamorelin, and CJC-1295 are sometimes self-sourced from unregulated online suppliers
Specific exercise approaches complement peptide therapy well
GLP-1 Works Best With Simple Habits 9